Activation of opioid μ-receptor by ioperamide to lower plasma glucose in streptozotocin-induced diabetic rats

I. Min Liu, Tzong Cherng Chi, Yun Chueh Chen, Feng Hwa Lu, Juei Tang Cheng

研究成果: Article同行評審

40 引文 斯高帕斯(Scopus)

摘要

We investigated the effect of loperamide, a selective agonist of opioid μ-receptor, on the plasma glucose in diabetic rats induced by an intravenous injection of streptozotocin (STZ; 60 mg/kg). Intravenous injection of loperamide induced a dose-dependent decrease of plasma glucose in fasting STZ-diabetic rats at 30 min later, but did not modify the plasma glucose level in Wistar rats. Plasma glucose lowering effect of loperamide was abolished by the pretreatment with naloxone or naloxonazine at the dose sufficient to block opioid μ-receptor. In isolated skeletal muscle, loperamide enhanced the glucose uptake into soleus muscles in a concentration-dependent manner. Blockade of this action by naloxonazine indicated the mediation of opioid μ-receptor. These results suggest that an activation of opioid μ-receptor by loperamide can increase the utilization of glucose in peripheral tissue to lower the plasma glucose in STZ-diabetic rats.

原文English
頁(從 - 到)183-186
頁數4
期刊Neuroscience Letters
265
發行號3
DOIs
出版狀態Published - 1999 4月 23

All Science Journal Classification (ASJC) codes

  • 神經科學 (全部)

指紋

深入研究「Activation of opioid μ-receptor by ioperamide to lower plasma glucose in streptozotocin-induced diabetic rats」主題。共同形成了獨特的指紋。

引用此